Genus Prime

Which are the latest news on Genus Prime?

Why is Genus Prime Infra Ltd falling/rising?

As of 18-Jul, Genus Prime Infra Ltd's stock price is rising to 29.84, marking a 5.0% increase after five days of decline, indicating a potential trend reversal. The stock has outperformed its sector by 6.04%, despite a slight decrease in investor participation.

As of 18-Jul, Genus Prime Infra Ltd's stock price is rising, currently at 29.84, reflecting a change of 1.42 or 5.0% increase. This upward movement is notable as it comes after five consecutive days of decline, indicating a potential trend reversal. The stock opened with a significant gain of 9.04% today and reached an intraday high of Rs 31.26, showcasing strong intraday performance.<BR><BR>Additionally, the stock has outperformed its sector by 6.04%, suggesting that it is gaining traction relative to its peers. Despite a decrease in investor participation, with delivery volume falling by 2.5% against the five-day average, the stock remains liquid enough for trading purposes. Overall, the combination of a strong opening, a reversal after a period of decline, and outperformance against the sector contributes to the rising stock price of Genus Prime Infra Ltd.

Should I buy, sell or hold Genus Prime Infra Ltd?

How big is Genus Prime?

As of 10th June, Genus Prime Infra Ltd has a market capitalization of 236.00 Cr, classifying it as a Micro Cap company, with recent Net Sales of 4.25 Cr and a Net Profit of 4.58 Cr.

As of 10th June, Genus Prime Infra Ltd has a market capitalization of 236.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest four quarters, Genus Prime reported Net Sales of 4.25 Cr and a Net Profit of 4.58 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 46.17 Cr and Total Assets valued at 66.83 Cr.

Who are in the management team of Genus Prime?

The management team of Genus Prime includes Amit Agarwal (Whole Time Director & CEO), Simpal Agarwal (Director), and independent directors Dharam Chand Agarwal, Kamal Kant Agarwal, and Udit Agarwal.

The management team of Genus Prime includes the following individuals:<BR><BR>1. Dharam Chand Agarwal - Independent Director<BR>2. Kamal Kant Agarwal - Independent Director<BR>3. Amit Agarwal - Whole Time Director & CEO<BR>4. Simpal Agarwal - Director<BR>5. Udit Agarwal - Independent Director<BR><BR>If you need more details about their roles or the company, feel free to ask!

Who are the peers of the Genus Prime?

Genus Prime's peers include Lords Chloro, Mangalam Organic, Alufluoride, National Perox., Hind.Organ.Chem., ZR2 Bioenergy, Kesar Petroprod., IVP, and Kanchi Karpooram. Alufluoride shows excellent management and growth, while Genus Prime has below average management risk and capital structure, with a 1-year return of 14.63%.

Peers: The peers of Genus Prime are Lords Chloro, Mangalam Organic, Alufluoride, National Perox., Hind.Organ.Chem., ZR2 Bioenergy, Kesar Petroprod., IVP, and Kanchi Karpooram.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride, while Average management risk is found at Lords Chloro, Mangalam Organic, Kesar Petroprod., and IVP, and the rest. Below Average management risk is present at Genus Prime, Hind.Organ.Chem., ZR2 Bioenergy. Growth is Good at Alufluoride, Genus Prime, and Kesar Petroprod., while Average growth is noted at IVP and the rest, and Below Average growth is seen at Mangalam Organic, National Perox., Hind.Organ.Chem., ZR2 Bioenergy, and Kanchi Karpooram. Capital Structure is Excellent at Kanchi Karpooram, Good at Alufluoride and National Perox., Average at Lords Chloro, and the rest, and Below Average at Genus Prime, Mangalam Organic, Hind.Organ.Chem., ZR2 Bioenergy, Kesar Petroprod., and IVP.<BR><BR>Return Snapshot: Alufluoride has the highest 1-year return at 13.80%, while ZR2 Bioenergy has the lowest at -68.86%. Genus Prime's 1-year return of 14.63% is higher than both. Additionally, ZR2 Bioenergy, Kesar Petroprod., and Kanchi Karpooram have negative six-month returns.

What does Genus Prime do?

Genus Prime Infra Ltd is a micro-cap real estate development company, formerly known as Gulshan Chemfill Ltd, with a market cap of INR 236 Cr and reported net sales of 1 Cr and net profit of 4 Cr for the quarter ending March 2026. It operates as a subsidiary of Genus Paper Products Limited.

Overview: <BR>Genus Prime Infra Ltd operates primarily in the real estate development sector and belongs to the commodity chemicals industry within the micro-cap market.<BR><BR>History: <BR>The company was incorporated in 2000 and was formerly known as Gulshan Chemfill Ltd. It currently operates as a subsidiary of Genus Paper Products Limited. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 1 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 4 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 236 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 53.00 <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.18 <BR>Return on Equity: 2.12% <BR>Price to Book: 1.09 <BR><BR>Contact Details: <BR>Address: Near Moradabad Dharam Kanta, Kanth Road Harthala Moradabad Muzaffarnagar Uttar Pradesh : 244001 <BR>Tel: 91-591-2511171 <BR>Email: cs.genusprime@gamil.com <BR>Website: http://www.genusprime.com

Are Genus Prime Infra Ltd latest results good or bad?

Genus Prime Infra Ltd's latest results show a significant profit increase of 2,540% to ₹3.96 crores, largely driven by non-operating income, while net sales declined by 5.69%. Despite improved operating margins, the reliance on other income and low return on equity indicate underlying challenges, suggesting caution for investors.

The latest results for Genus Prime Infra Ltd present a mixed picture. On one hand, the company reported a consolidated net profit of ₹3.96 crores for Q4 FY26, which is a remarkable increase of 2,540% compared to the previous quarter. This surge in profit is impressive; however, it is largely attributed to a significant reliance on other income, which accounted for 76.32% of profit before tax. This raises concerns about the sustainability and quality of the earnings.<BR><BR>On the other hand, net sales for the same quarter were ₹1.16 crores, reflecting a decline of 5.69% from the previous quarter. While this represents a staggering year-on-year growth of 5,700% from a very low base, the sequential drop indicates inconsistency in revenue generation. The operating margin, excluding other income, was exceptionally high at 131.9%, up from 67.48% in the previous quarter, suggesting improved cost management, but again, the sustainability of such margins is questionable given the company's current scale.<BR><BR>Moreover, the return on equity (ROE) remains very low at 0.19%, indicating weak capital efficiency. Overall, while the profit figures may seem positive at first glance, the heavy reliance on non-operating income and the decline in sales suggest that the underlying business is facing significant challenges. Therefore, the results can be viewed as concerning rather than outright good. Investors should approach with caution, considering the potential risks associated with the company's financial health and operational consistency.

Is Genus Prime overvalued or undervalued?

As of November 17, 2025, Genus Prime is considered very expensive and overvalued, with a PE ratio of 75.33 and an EV to EBITDA of 43.64, significantly higher than its peers, and has experienced an 18.60% year-to-date decline compared to an 8.72% rise in the Sensex.

As of 17 November 2025, the valuation grade for Genus Prime has moved from risky to very expensive. This indicates a significant shift in perception regarding the company's valuation, suggesting that it is currently overvalued. The company’s PE ratio stands at an exceptionally high 75.33, while its EV to EBITDA ratio is 43.64, both of which are considerably above industry norms. Additionally, the PEG ratio is a mere 0.02, indicating that the stock is priced excessively relative to its growth potential.<BR><BR>In comparison to its peers, Genus Prime's valuation metrics are starkly higher than those of Godrej Industries, which has a PE ratio of 37.63 and an EV to EBITDA of 40.96, making it appear relatively more attractive. Other peers, such as Gujarat Fluoroch, also show lower valuations with a PE of 57.85 and an EV to EBITDA of 31.25. Given these ratios and the overall market context, Genus Prime is deemed overvalued. Despite a strong historical performance over the long term, recent returns indicate a decline, with a year-to-date drop of 18.60% compared to an 8.72% rise in the Sensex, reinforcing the concerns about its current valuation.

How has been the historical performance of Genus Prime?

Genus Prime has consistently reported low net sales and negative profitability, with stable sales figures around 0.22 Cr but significant losses, particularly in Mar'24. The company faces ongoing financial challenges, reflected in negative profit margins and declining reserves.

Answer:<BR>The historical performance of Genus Prime shows a consistent trend of low net sales and negative profitability over the years.<BR><BR>Breakdown:<BR>Genus Prime's net sales have remained relatively stable, with figures of 0.22 Cr in Mar'25, Mar'23, and Mar'22, while slightly decreasing from 0.23 Cr in Mar'24 and Mar'20. The total operating income mirrored this trend, remaining at 0.22 Cr for Mar'25, Mar'23, and Mar'22. However, the company's total expenditure saw a significant spike in Mar'24 to 2.23 Cr, leading to an operating profit of -2.00 Cr, which improved to -0.04 Cr in Mar'25. The profit before tax followed a similar pattern, with a loss of -2.00 Cr in Mar'24 and a reduced loss of -0.04 Cr in Mar'25. The profit after tax also reflected these losses, with -2.00 Cr in Mar'24 and -0.04 Cr in Mar'25. The company's total liabilities decreased from 69.57 Cr in Mar'24 to 66.83 Cr in Mar'25, while total assets also declined from 69.57 Cr to 66.83 Cr in the same period. Cash flow from operating activities was non-existent in recent years, indicating challenges in generating cash from core operations. Overall, Genus Prime has faced ongoing financial difficulties, reflected in its negative profit margins and declining reserves.

Who are the top shareholders of the Genus Prime?

The top shareholder of Genus Prime is promoter Rajendra Agarwal, holding 29.26%. Other notable shareholders include Arham Vyapaar Private Limited at 3.57% and individual investors with a collective 18.66%.

The top shareholders of Genus Prime include Rajendra Agarwal, who is the promoter with the highest holding at 29.26%. The company does not have any pledged promoter holdings, and there are no mutual funds or foreign institutional investors holding shares. The highest public shareholder is Arham Vyapaar Private Limited, which holds 3.57%. Additionally, individual investors collectively hold 18.66% of the shares.

What is the technical trend for Genus Prime?

As of May 26, 2025, Genus Prime's technical trend is mildly bullish, supported by daily moving averages and Bollinger Bands, despite some caution from weekly and monthly MACD and KST indicators.

As of 26 May 2025, the technical trend for Genus Prime has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD and KST are both mildly bearish, suggesting some caution. However, the Bollinger Bands on both weekly and monthly time frames are bullish, supporting the overall mildly bullish trend. The Dow Theory shows a mildly bullish signal on the weekly chart but no trend on the monthly. Despite recent underperformance in the weekly return compared to the Sensex, the longer-term returns are significantly strong, particularly over 3, 5, and 10 years. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and Bollinger Bands.

When is the next results date for Genus Prime?

No Upcoming Board Meetings

Has Genus Prime declared dividend?

No Dividend History Available